GlassScriptPhysician profile
Esther M Carson
NPI 1073588679
$1,020.47
in general payments reported to CMS, 2019-2025
7 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $114 · 2023: $192 · 2024: $225 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.56 |
| Education | $143.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $442.31 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $293.71 | 2022-2025 | Tremfya |
| Leo Pharma INC. | $113.78 | 2025 | Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $92.77 | 2022-2024 | Sotyktu |
| Abbvie INC. | $42.08 | 2025 | |
| Arcutis Biotherapeutics, INC. | $18.40 | 2023 | |
| Sun Pharmaceutical Industries INC. | $17.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.